Emerging evidence demonstrates that in acute myeloid leukemia (AML) patients, MSLN is predominantly expressed in the CD45dim/SSC-Alow myeloid cell subpopulation and exhibits minimal expression in mature lymphocytes and monocytes.46 Here, MSLN is linked to acute myeloid leukemia.